Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: Results Through 24 Months From a Phase 1 Study

Author:Sarva, Harini   Henchcliffe, Claire   Lozano, Andres   Fasano, Alfonso   Kalia, Suneil   Yu, Kenny Kwok Hei   Brennan, Cameron   Floro, Nicole   Stemple, Whitney   Abid, Nauman   Tabar, Viviane   

Session Name:S37: Movement Disorders: Clinical Trials  

Topic:Movement Disorders  

Program Number:S37.005  

Author Institution:Department of Neurology, Weill Cornell Medicine, New York, NY, USA, New York, NY  Department of Neurology, University of California, Irvine, CA, USA, Orange, CA  Department of Neurosurgery and Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center, New York, NY, USA, New York, NY  BlueRock Therapeutics LP, Cambridge, MA, USA, Cambridge, MA  

A Noninterventional Study to Evaluate Real-world Feasibility, Compliance, and Satisfaction with Digital Health Technologies for Parkinson’s Disease

Author:Abid, Nauman   Stemple, Whitney   Komuravelli, Madhu Kumar   

Session Name:P11: Movement Disorders: Therapeutics in Study for Parkinson's Disease  

Topic:Movement Disorders  

Program Number:P11.022  

Author Institution:BlueRock Therapeutics LP, Cambridge, MA  BlueRock Therapeutics LP, San Marcos, CA